Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] loss -9.36% or -0.17 points to close at $1.70 with a heavy trading volume of 4575394 shares. The daily chart for LXRX points out that the company has recorded 42.44% gains over the past six months. If we look at
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock went on a downward path that fall over -7.69% on Wednesday, amounting to a one-week price increase of more than 3.03%. The company report on April 3, 2024 at 8:00 AM that Lexicon Pharmaceuticals to Participate in the 23rd
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] jumped around 0.21 points on Wednesday, while shares priced at $2.19 at the close of the session, up 10.61%. The company report on March 25, 2024 at 9:20 AM that Clinical Data on the Impact of Sotagliflozin on Stroke and
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock went on a downward path that fall over -3.21% on Thursday, amounting to a one-week price decrease of less than -0.82%. The company report on March 12, 2024 at 8:00 AM that New Post Hoc Analysis of inTandem3 Study
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] jumped around 0.64 points on Monday, while shares priced at $2.81 at the close of the session, up 29.49%. The company report on March 11, 2024 at 7:15 AM that Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] gained 7.38% or 0.18 points to close at $2.62 with a heavy trading volume of 5978469 shares. The company report on January 8, 2024 at 7:00 AM that Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock went on a downward path that fall over -16.67% on Tuesday, amounting to a one-week price decrease of less than -9.25%. The company report on January 8, 2024 at 7:00 AM that Lexicon Pharmaceuticals Provides Business and Pipeline Update
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] jumped around 0.53 points on Monday, while shares priced at $2.92 at the close of the session, up 22.18%. The company report on January 8, 2024 at 7:00 AM that Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock went on a downward path that fall over -2.71% on Wednesday, amounting to a one-week price increase of more than 14.97%. The company report on January 8, 2024 at 7:00 AM that Lexicon Pharmaceuticals Provides Business and Pipeline Update
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] jumped around 0.11 points on Wednesday, while shares priced at $1.87 at the close of the session, up 6.25%. The company report on January 8, 2024 at 7:00 AM that Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual
© 2024, Powered by Smart TechOne
